CoreCap Advisors’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$524 Hold
100
﹤0.01% 2847
2026
Q1
$176 Hold
100
﹤0.01% 2772
2025
Q4
$235 Hold
100
﹤0.01% 2796
2025
Q3
$306 Hold
100
﹤0.01% 2626
2025
Q2
$279 Hold
100
﹤0.01% 2583
2025
Q1
$359 Sell
100
-50
-33% -$201 ﹤0.01% 2774
2024
Q4
$472 Buy
150
+50
+50% +$179 ﹤0.01% 2532
2024
Q3
$282 Buy
+100
New +$229 ﹤0.01% 2435
2024
Q2
Sell
-100
Closed -$79 1786
2024
Q1
$79 Buy
+100
New +$91 ﹤0.01% 2456
2022
Q4
$1.04K Buy
+1,120
New +$1.5K ﹤0.01% 2049
2022
Q3
Sell
-1,120
Closed -$2K 804
2022
Q2
$2K Buy
+1,120
New +$2.98K ﹤0.01% 1844
2022
Q1
Sell
-600
Closed -$2K 819
2021
Q4
$2K Buy
+600
New +$3.68K ﹤0.01% 1936

Other funds holding CLOV

CoreCap Advisors's CLOV Position: Q2 2026 in Review

CoreCap Advisors held its Clover Health Investments (CLOV) position steady in Q2 2026 at 100 shares worth $524. The position accounts for ﹤0.01% of the portfolio, ranked #2847.

CoreCap Advisors first reported a position in CLOV in Q4 2021 and has held it in 12 quarters since. The position peaked at $2K in Q2 2022. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • CoreCap Advisors held 100 shares of Clover Health Investments worth $524 as of Q2 2026.
  • CoreCap Advisors left its Clover Health Investments share count unchanged in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2847 holding.
  • CoreCap Advisors first reported a position in Clover Health Investments in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's Clover Health Investments position peaked at $2K in Q2 2022.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.